Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centers.
George
M J
MJ
Institut Gustave Roussy, Villejuif, France.
Heron
J F
JF
Kerbrat
P
P
Chauvergne
J
J
Goupil
A
A
Lebrun
D
D
Guastalla
J P
JP
Namer
M
M
Bugat
R
R
Ayme
Y
Y
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy*; D003131:Combined Modality Therapy; D003248:Constipation / Q000139:chemically induced; D004341:Drug Evaluation; D005260:Female; D005602:France; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009325:Nausea / Q000139:chemically induced; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D012074:Remission Induction; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077235:Vinorelbine; D014839:Vomiting / Q000139:chemically induced
D000970:Antineoplastic Agents; D014747:Vinblastine; D000077235:Vinorelbine